Certara, Inc. (CERT) vs Ocular Therapeutix, Inc. (OCUL)
A side-by-side comparison of Certara, Inc. and Ocular Therapeutix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CERT
Certara, Inc.
$9.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OCUL
Ocular Therapeutix, Inc.
$7.34HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CERT vs OCUL
growth of $100 · dividends reinvested · last 6yCERT -73.6% (-19.9%/yr)OCUL -65.0% (-16.1%/yr)OCUL compounded faster over this window
CERT OCUL
CERT vs OCUL: by the numbers
- •OCUL is the larger company ($1.61B vs $1.44B market cap).
- •Both run net losses; CERT's is the smaller (-16.75% vs -579.10% net margin).
- •OCUL grew revenue faster over the past five years (10.03% vs 9.31% CAGR).
Metrics side by side
Valuation
| Metric | CERT | OCUL |
|---|---|---|
| Forward P/E | 27.22 | N/A |
| P/S ratio | 3.53 | 30.87 |
| P/B ratio | 1.49 | 3.09 |
| EV / EBITDA | 26.24 | N/A |
| FCF yield | 4.27% | N/A |
Profitability
| Metric | CERT | OCUL |
|---|---|---|
| Gross margin | 58.33% | 87.11% |
| Operating margin | 1.86% | -521.04% |
| Net margin | -16.75% | -579.10% |
| ROE | -7.08% | -57.97% |
| ROIC | 0.59% | -50.20% |
Growth (annualized)
| Metric | CERT | OCUL |
|---|---|---|
| Revenue CAGR (5Y) | 9.31% | 10.03% |
| FCF CAGR (5Y) | 8.78% | N/A |
| Total return CAGR (5Y) | -21.31% | -5.73% |
Frequently asked
- Which has grown faster, CERT or OCUL?
- Over the past five years, OCUL grew revenue faster — CERT at a 9.31% CAGR versus OCUL at 10.03%.
- How have CERT and OCUL total returns compared?
- Over the past 5 years, CERT delivered -21.31% and OCUL delivered -5.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Certara ROEOcular Therapeutix ROECertara operating marginOcular Therapeutix operating marginCertara revenue growthOcular Therapeutix revenue growthCertara free cash flowOcular Therapeutix free cash flow
Certara & Ocular Therapeutix appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.